Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01569295||Active, not recruiting
|A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)||
||416||All||18 Years and older (Adult, Older Adult)||NCT01569295||GS-US-312-0115
|Tugela||June 26, 2012||October 7, 2015||May 2019||April 3, 2012||May 14, 2019||February 27, 2018||